News AegirBio AB

Equities

AEGIR

SE0014401121

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 01/07/2024 pm IST			5-day change	1st Jan Change
0.425 ^SEK	-11.09%		-3.95%	-63.68%

04/06	Sweden's AegirBio to Change Name to MagnOral	MT
17/05	AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AegirBio AB has received payment of Tranche 2 of SEK 5.00 million from Atlas Special Opportunities, LLC	27/06	AQ
AegirBio receives second milestone payment under RadX NIH	11/06	AQ
Sweden's AegirBio to Change Name to MagnOral	04/06	MT
AegirBio announces strategic name change to MagnOral AB	04/06	AQ
AegirBio AB carries out previously announced directed share issue of 5,175,374 shares corresponding to approximately SEK 2.54 million to Atlas Special Opportunities and calls for payment of Tranche 2	31/05	AQ
AegirBio's CEO Marco Witteveen to Attend SalivaDirect's 3rd Annual Conference in Washington, DC, June 5-7, 2024	29/05	AQ
AEGIRBIO AB SUCCESSFULLY COMPLETES AN ADDITIONAL MILESTONE OF RADx® TECH PROGRAM	21/05	AQ
AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05	CI
AEGIRBIO study published in Multiple Sclerosis and Related Disorders journal	16/05	AQ
AegirBio AB Announces the Findings of Recent Study Published in the Multiple Sclerosis and Related Disorders Journal	16/05	CI
AegirBio AB calls for payment of Tranche 1 of SEK 7.50 million and intends to carry out a directed set-off issue of 5,175,374 shares to Atlas Special Opportunities, LLC	13/05	AQ
AEGIRBIO Receives Milestone Payment under RadX NIH	08/05	AQ
AEGIRBIO AB ADVANCES FURTHER WITH "ACCESSIBILITY" MILESTONE COMPLETION IN RADx® TECH PROGRAM	30/04	AQ
AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract	19/04	MT
AegirBio AB's subsidiary initiates arbitration against Salofa Oy	18/04	AQ
AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas	09/04	MT
AegirBio Chairman to Resign	09/04	MT
AegirBio's chairman has announced his intention to leave the board of directors	09/04	AQ
AegirBio AB Announces Intention of Anders Ingvarsson to Resign as Board Member and Chairman	09/04	CI
AegirBio enters into a conditional agreement on a MSEK 45 loan facility with Atlas Special Opportunities and an agreement to amend the outstanding convertible bonds, subject to EGM approval	09/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AegirBio AB

Equities

AEGIR

SE0014401121

Summary

Filters